CJC-1295 + Ipamorelin — Compound Overview
A researcher-focused overview of the CJC-1295 + Ipamorelin blend: what it contains, how the two peptides differ, and how Index Peptides documents each batch.
Last updated: 2026-08-21 · By: Index Peptides technical team
Key facts
| Compound | CJC-1295 + Ipamorelin |
|---|---|
| Supplied formats | 10mg per vial |
| Intended use | In-vitro laboratory research only |
What is the CJC-1295 + Ipamorelin blend?
This vial co-formulates two research peptides: CJC-1295, a modified GRF(1-29) analogue, and ipamorelin, a synthetic pentapeptide growth hormone secretagogue. Blending is a formulation choice; each peptide retains its own identity and documentation.
Both components are classified as research chemicals. Neither is an approved medicine, and both are prohibited in sport by the World Anti-Doping Agency (WADA).
Documenting a blend
A blend cannot be documented with a single purity figure. The batch record for this product identifies each peptide and reports purity for each on the same certificate as the lot you receive.
Form, handling and storage
The blend is supplied as a lyophilised (freeze-dried) powder in a sealed vial. Lyophilised peptides are best stored at -20°C, desiccated and protected from light; long-term stability data are batch-specific and recorded against the batch record.
Batch documentation at Index Peptides
Every released batch is HPLC purity tested per peptide and LC-MS identity confirmed, with the certificate of analysis published on the product page and verifiable by lot number through the batch lookup tool.
Frequently asked questions
Is CJC-1295 + Ipamorelin approved for human use?
No. Neither component is an approved medicine. Index Peptides supplies this blend strictly for in-vitro laboratory research — not for human or animal consumption, administration or any in-vivo use.
How is a blend verified?
The batch COA identifies each peptide and reports purity for each on the same record as the lot. You can check any batch by lot number on the verify page.
Which formats does Index Peptides supply?
This blend is supplied as one co-formulated 10mg vial, alongside the separate CJC-1295 (DAC) and ipamorelin single-compound vials.
How do I reconstitute CJC-1295 + Ipamorelin?
Reconstitution is a laboratory handling procedure, not a use instruction. Our documentation-led reconstitution guide covers the mechanics of dissolving lyophilised peptide powders: https://indexpeptides.uk/guides/peptide-reconstitution-guide. Handling is the responsibility of the qualified researcher.
What is the shelf life of CJC-1295 + Ipamorelin?
As supplied (lyophilised powder in a sealed vial), CJC-1295 + Ipamorelin is stored at -20C, desiccated and protected from light. Long-term stability is documented per batch on the certificate of analysis; treat the batch record as the authoritative shelf-life reference for that lot.
What is the difference between the sizes?
The difference is the nominal peptide content per vial. CJC-1295 + Ipamorelin is supplied as one co-formulated 10mg blend vial. Every format carries the same batch documentation and purity testing.
What does the certificate of analysis show?
Every released batch of CJC-1295 + Ipamorelin is documented with its certificate of analysis: the purity results, identity confirmation and the lot number, published on the product page and checkable through the batch lookup tool. The COA is the authoritative record for that batch.
What are the molecular weights of the components?
This is a co-formulated blend of two peptides, CJC-1295 (modified GRF 1-29) and ipamorelin, each with its own molecular weight. The batch COA records the identity confirmation for each component.
References
Research use only. Not for human or animal consumption.